Research article · 24 Feb 2025
Conference abstractPublished 19 Jun 2013
C-kit, Erb2, EGFR and AKT expression in uterine carcinosarcomas: An exploratory study
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Uterine carcinosarcomas (UCS) result in ~15% of uterine cancer-associated deaths. C-kit, ERBB2, EGFR and AKT expressions were studied by immunohistochemistry, in order to evaluate their roles in the pathogenesis of UCS. In addition, exons 9 and 20 of PIK3CA gene, a critical gene in the AKT pathway, have been sequenced with ABI 3130xl Genetic Analyzer. The cohort (n=37) was composed of twenty-three early-stage (I and II) and fourteen late-stage (III and IV) tumors. The majority of carcinomatous components were pure serous adenocarcinoma (n=13). Fourteen cases showed heterologous elements in the sarcomatous components. An immunostaining score (IS) ranging from 0 to (6+) was calculated for C-kit, EGFR and AKT by adding the score of intensity and the percentage of positively stained cells. ASCO/CAP guidelines were used to evaluate ERBB2. AKT was positive in 35/37 cases with an IS ranging from (2+) to (5+). ERBB2 immunostain was (3+) in one case. EGFR was positive in 21/37 cases. Only six cases showed low IS with C-kit. AKT was expressed significantly more in the early-stage disease than late-stage disease (p=0.016). The sarcomatous component had a significantly higher IS than that of epithelial component (p=0.006). The expression of AKT in the epithelial component was associated with the survival (p=0.026). In one case, H1047R mutation on PIK3CA gene has been detected in both carcinomatous and sarcomatous components. These results indicate that AKT pathway is important in pathogenesis of UCS. Further studies with larger cohorts are warranted to confirm the observed associations in this study.
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical & Experimental Pathology.
Research article · 3 Feb 2025
Outbreak of Crimean Congo Haemorrhagic Fever in Northern Senegal in 2022
Review article · 16 Jan 2025
Recent Updates on Huntington Disease
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Pathology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Ozlen Saglam”
- BylineArticles whose byline prints “Seema Husain”
- BylineArticles whose byline prints “Gokce Toruner”